In addition, in specific models of “MI plus type 2 diabetes,” exogenous supplementation or overexpression of FSTL1 reduced myocardial fibrosis and improved cardiac function through the USP10/Notch1 axis. The gene discussed is NOTCH1; the disease is Myocardial fibrosis.